RIBOSPHERE

Serial Number 79272256
Registration 6366560
700

Registration Progress

Application Filed
Aug 6, 2019
Under Examination
Approved for Publication
Mar 16, 2021
Published for Opposition
Mar 16, 2021
Registered
Jun 1, 2021

Trademark Image

RIBOSPHERE

Basic Information

Serial Number
79272256
Registration Number
6366560
Filing Date
August 6, 2019
Registration Date
June 1, 2021
Published for Opposition
March 16, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 1, 2021
Registration
Registered
Classes
042 044

Rights Holder

BioNTech SE

99
Address
An der Goldgrube 12
55131 Mainz
DE

Ownership History

BioNTech RNA Pharmaceuticals GmbH

Original Applicant
99
DE

BioNTech RNA Pharmaceuticals GmbH

Owner at Publication
99
DE

BioNTech SE

Original Registrant
99
DE

Legal Representation

Attorney
Monica Riva Talley

USPTO Deadlines

Next Deadline
509 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20210601)
Due Date
June 01, 2027
Grace Period Ends
December 01, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

41 events
Date Code Type Description Documents
Jan 31, 2025 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
May 30, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 30, 2024 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
May 30, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 30, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 30, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 30, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Nov 19, 2021 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Oct 10, 2021 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Sep 21, 2021 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Sep 21, 2021 FIMP P FINAL DISPOSITION PROCESSED Loading...
Sep 1, 2021 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jun 1, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 10, 2021 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Apr 21, 2021 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Apr 21, 2021 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Mar 16, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 16, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 14, 2021 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Feb 24, 2021 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Feb 24, 2021 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Feb 24, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 5, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 4, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 4, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 4, 2021 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Aug 9, 2020 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Aug 9, 2020 GNFR O FINAL REFUSAL E-MAILED Loading...
Aug 9, 2020 CNFR R FINAL REFUSAL WRITTEN Loading...
Jun 27, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 26, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 26, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 17, 2020 RFNT P REFUSAL PROCESSED BY IB Loading...
Dec 27, 2019 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Dec 27, 2019 RFRR P REFUSAL PROCESSED BY MPU Loading...
Dec 2, 2019 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Dec 1, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 26, 2019 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Nov 22, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 22, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 21, 2019 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 042
Scientific research for medical and veterinary purposes in the field of treatment of cancer, autoimmune disorders, genetic defects, and metabolic disorders, using liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or emulsions
Class 044
Medical and veterinary services in connection with cancer diseases, autoimmune disorders, genetic defects, and metabolic disorders

Additional Information

Pseudo Mark
RIBO SPHERE

Classification

International Classes
042 044